Knight Therapeutics Inc Environmental Analytics
Environmental and financial analysis dashboard for Knight Therapeutics Inc. Industry: MANUFACTURING
Company Overview for Knight Therapeutics Inc
Highlights
Showing data for FY2022
Operational Environmental Cost
$3.00m
Operational Environmental Cost Intensity
1.38%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$1.67m
Decoupling Rate (2020-2022)
-28%
Adjusted EBITDA
$16m
Adjusted EBITDA Margin
7.22%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 51.64% | 42.50% | 26.03% | ||
| 0.29% | 0.36% | 0.45% | 0.50% | |
| 61.02% | 43.79% | 37.10% | ||
| 0.56% | 0.73% | 0.93% | 1.11% | |
| $1m | $2m | $3m | $4m | |
| 57.81% | 43.37% | 33.48% | ||
| 0.85% | 1.09% | 1.38% | 1.61% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
7.22%
Adjusted EBIT Margin
-14%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$157m | $193m | $217m | $249m | |
| 23.08% | 12.40% | 14.88% | ||
$104m | $147m | $198m | $218m | |
| 66.14% | 76.09% | 91.40% | 87.54% | |
$53m | $46m | $19m | $31m | |
| 33.86% | 23.91% | 8.60% | 12.46% | |
$28m | $8m | $-28m | $-7m | |
| 17.78% | 4.23% | -12.73% | -2.89% | |
| ENVIRONMENTAL COST DATA | ||||
$1m | $2m | $3m | $4m | |
| 0.85% | 1.09% | 1.38% | 1.61% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$52m | $44m | $16m | $27m | |
| 33.01% | 22.83% | 7.22% | 10.85% | |
$27m | $6m | $-31m | $-11m | |
| 16.94% | 3.15% | -14.11% | -4.50% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
MANUFACTURE OF PHARMACEUTICAL PREPARATIONS
Scope 1 (% of Sales)
0.45%
Scope 2 (% of Sales)
0.93%
Operational Environmental Cost Intensity
1.38%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Knight Therapeutics Inc | N/A | $3m | 1.38% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022